-
1دورية أكاديمية
المؤلفون: Chandran, Elias, Goswami, Meghali, Donahue, Renee Nicole, Atiq, Mohammad O., Karzai, Fatima, Bilusic, Marijo, Marte, Jennifer L., Arlen, Philip M., Cordes, Lisa M., Owens, Helen, Hausler, Megan, Hankin, Amy, Williams, Monique, Dahut, William L., Figg, William Douglas, Schlom, Jeffrey, Gulley, James L., Madan, Ravi Amrit
المصدر: Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, p207-207, 1p
-
2دورية أكاديمية
المؤلفون: Ning YM; PharmD, Bldg 10/Rm 5A01, 10 Center Dr, Bethesda, MD 20892, USA., Gulley JL, Arlen PM, Woo S, Steinberg SM, Wright JJ, Parnes HL, Trepel JB, Lee MJ, Kim YS, Sun H, Madan RA, Latham L, Jones E, Chen CC, Figg WD, Dahut WL
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Apr 20; Vol. 28 (12), pp. 2070-6. Date of Electronic Publication: 2010 Mar 22.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Intramural
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Orchiectomy*, Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prostatic Neoplasms/*drug therapy, Adenocarcinoma/immunology ; Adenocarcinoma/secondary ; Adenocarcinoma/surgery ; Administration, Oral ; Adult ; Aged ; Angiogenesis Inhibitors/administration & dosage ; Animals ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics ; Bevacizumab ; Cell Line, Tumor ; Disease-Free Survival ; Docetaxel ; Down-Regulation ; Humans ; Infusions, Intravenous ; Kaplan-Meier Estimate ; Male ; Mice ; Mice, SCID ; Middle Aged ; Prednisone/administration & dosage ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/immunology ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Taxoids/administration & dosage ; Thalidomide/administration & dosage ; Time Factors ; Treatment Outcome ; Tumor Burden/drug effects ; Xenograft Model Antitumor Assays
-
3دورية أكاديمية
المؤلفون: Kantoff PW; Medical Director, BN ImmunoTherapeutics, 2425 Garcia Ave, Mountain View, CA 94043, USA., Schuetz TJ, Blumenstein BA, Glode LM, Bilhartz DL, Wyand M, Manson K, Panicali DL, Laus R, Schlom J, Dahut WL, Arlen PM, Gulley JL, Godfrey WR
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Mar 01; Vol. 28 (7), pp. 1099-105. Date of Electronic Publication: 2010 Jan 25.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Cancer Vaccines/*immunology , Poxviridae/*immunology , Prostate-Specific Antigen/*immunology , Prostatic Neoplasms/*therapy, Aged ; Aged, 80 and over ; Double-Blind Method ; Genetic Vectors/immunology ; Humans ; Immunization ; Male ; Middle Aged ; Neoplasm Metastasis ; Orchiectomy ; Prostate-Specific Antigen/antagonists & inhibitors ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Vaccines, Synthetic/immunology
-
4دورية أكاديمية
المؤلفون: Marshall JL; Lombardi Cancer Center, Georgetown University Medical Center, 3800 Reservoir Rd, NW, Washington, DC 20007, USA. marshalj@georgetown.edu, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2005 Feb 01; Vol. 23 (4), pp. 720-31. Date of Electronic Publication: 2004 Dec 21.
نوع المنشور: Clinical Trial; Clinical Trial, Phase I; Journal Article
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: B7-1 Antigen/*genetics , CD58 Antigens/*genetics , Cancer Vaccines/*immunology , Carcinoembryonic Antigen/*immunology , Granulocyte-Macrophage Colony-Stimulating Factor/*therapeutic use , Intercellular Adhesion Molecule-1/*genetics , Neoplasms/*therapy , Vaccines, Synthetic/*immunology, Adult ; Aged ; Aged, 80 and over ; Female ; Fowlpox virus/genetics ; Granulocyte-Macrophage Colony-Stimulating Factor/immunology ; Humans ; Immunoglobulin G/blood ; Male ; Middle Aged ; Neoplasms/immunology ; T-Lymphocytes/immunology ; Vaccination ; Vaccinia virus/genetics
-
5دورية أكاديمية
المؤلفون: Dahut WL; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2004 Jul 01; Vol. 22 (13), pp. 2532-9.
نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prostatic Neoplasms/*drug therapy, Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Docetaxel ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Prostate-Specific Antigen/analysis ; Prostatic Neoplasms/pathology ; Taxoids/administration & dosage ; Thalidomide/administration & dosage ; Treatment Outcome